Moxetumomab, CAS 1622075-65-3

Product Description: Moxetumomab, a recombinant CD22-targeting immunotoxin, can be used for the research of hairy cell leukemia (HCL)[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Sohita Dhillon. Moxetumomab Pasudotox: First Global Approval. Drugs. 2018 Nov;78(16):1763-1767./[2]Robert J Kreitman, et al. Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial. J Hematol Oncol. 2021 Feb 24;14(1):35.

CAS Number: 1622075-65-3

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer; Inflammation/Immunology

Solubility: H2O

Target: ADC Antibody;CD22

• Artikelnummer: MEXHY-P99034-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99034-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK